NDC 67751-214

Zantac 360

Famotidine

Zantac 360 is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Navajo Manufacturing Company Inc.. The primary component is Famotidine.

Product ID67751-214_e3278e75-9ba1-546e-e053-2995a90af170
NDC67751-214
Product TypeHuman Otc Drug
Proprietary NameZantac 360
Generic NameFamotidine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-08-01
Marketing CategoryANDA /
Application NumberANDA206531
Labeler NameNavajo Manufacturing Company Inc.
Substance NameFAMOTIDINE
Active Ingredient Strength20 mg/1
Pharm ClassesHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 67751-214-01

1 BLISTER PACK in 1 CARTON (67751-214-01) > 1 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2022-08-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Zantac 360" or generic name "Famotidine"

NDCBrand NameGeneric Name
0363-0141Acid ControllerFamotidine
0363-0701Acid ControllerFamotidine
0363-1203acid controllerfamotidine
0113-7141basic care acid reducerFamotidine
0113-7194Basic Care famotidineFamotidine
0093-2748FamotidineFamotidine
0172-5728FamotidineFamotidine
0172-5729FamotidineFamotidine
0338-5197FamotidineFamotidine
0363-0036FamotidineFamotidine
0363-1899FamotidineFamotidine
0363-4400FamotidineFamotidine
0113-0141good sense acid reducerFamotidine
0113-0194Good Sense Acid ReducerFamotidine
0187-4420Pepcidfamotidine
0187-4440Pepcidfamotidine

Trademark Results [Zantac 360]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZANTAC 360
ZANTAC 360
90179308 not registered Live/Pending
Chattem, Inc.
2020-09-14
ZANTAC 360
ZANTAC 360
90149088 not registered Live/Pending
Chattem, Inc.
2020-08-31

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.